INDIVIOR PLC DL 0,50/ GB00BN4HT335 /
2024-05-08 8:00:48 AM | Chg. -0.500 | Volume | Bid5:37:20 PM | Ask5:37:20 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
16.700EUR | -2.91% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 2.29 bill.EUR | - | - |
GlobeNewswire
04-18
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire
04-11
Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18,...
GlobeNewswire
04-03
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Mod...
GlobeNewswire
03-05
Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire
01-31
Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.
GlobeNewswire
2023-11-23
Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on Novem...
Newsfile Corp
2023-10-31
Pharma and Biotech Business Development Leaders to Discuss Psychedelics Partnering at Wonderland
GlobeNewswire
2023-09-06
Addex Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference